Auresine
  • Home
  • News
  • Technology
  • Applications
    • Laboratory use only
    • Diagnostics
    • Disinfectants
    • Food preservation
    • Animal welfare
    • Skin care
    • Wound care
  • Product
  • About us
    • Team
    • Grants
    • Publications
  • Contact
Zaznacz stronę

The project was presented at 3rd SMB Symposium for PhD Students, 14.06.2019 – Dziekanów, Poland

Our PhD student – Paweł Mitkowski – participated in 3rd SMB Symposium for PhD Students, Dziekanów, Poland. He presented his latest research on the poster – “EnpA catalytic domain as broad range bacteriolytic agent – structural studies and specificity determination”....

Auresine technology promoted at 3rd Interdisciplinary FNP Conference, 11-12.04.2019 – Warsaw, Poland

Izabela Sabała promoted Auresine technology at 3rd Interdisciplinary FNP Conference in Warsaw. The conference was addressed to the leaders of the projects that have received funding from the Foundation for Polish Science. It was an excellent opportunity to exchange...

The latest results of the project were presented at AMR Conference, 14-15.03.2019 – Berlin, Germany

The Auresine technology was promoted by Izabela Sabała during 3rd AMR Conference in Berlin. The ARM Conference aimed at bringing together SMEs, start-ups, big pharma, academia and investors to discuss strategies of transferring newly developed antimicrobials to the...

Auresine technology presented at The bacterial cell envelope „A 12-YEAR-JOURNEY”, 10-13.03.2019 – Tybinga, Germany

Our team – Izabela Sabała and Alicja Wysocka – participated in The 6th International Symposium on „The Bacterial Cell Envelope: A 12-year-journey”. The conference took place on the campus of the University of Tübingen in Germany. We had the opportunity to...

The latest results of the project were presented at The Lysing Meeting, New York, USA

Elżbieta Jagielska attended The Lysing Meeting (3-8 Nov 2018) in New York, USA and presented recent results on peptidoglycan recognition and binding by lysostaphin. Abstract Peptidoglycan recognition by lysostaphin SH3b domain Lysostaphin is the most studied potential...
« Starsze wpisy
Kolejne wpisy »

Latest News

  • We are hiring !!!
    19/11/2020
  • BioConvention Digital – 8-12 June, 2020
    21/05/2020
  • February 2020 – Portugal & Germany
    23/02/2020
  • Merry Christmas
    23/12/2019
  • Medica 2019 – Come and see us at Stand no. 16A21, Hall 16
    14/11/2019
  • Auresine team attended III Wound Management Forum, 10-12 October 2019, Karpacz, Poland
    10/10/2019
  • The Great Wall Symposium, 25-27 September 2019, Paris, France
    25/09/2019
  • Auresine team attended Workshop on data collection and structure solving in macromolecular X-ray diffraction, 12-16.07.2019 – Cracow, Poland
    12/07/2019

Copyright © 2023 Auresine•Developed by: webmania.pl